Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...

The Food and Drug Administration has approved Zepbound to treat obstructive sleep apnea for people who are moderately or ...

This weight-loss drug, designed for obese patients, significantly reduces breathing disruptions and offers a new treatment ...

Vivos Therapeutics, with its groundbreaking FDA-cleared treatments ... Dec. 16, 2024 /PRNewswire-PRWeb/ -- Pediatric Obstructive Sleep Apnea (OSA) is a silent health crisis affecting an estimated ...

Nyxoah SA (NASDAQ:NYXH), a medical technology company specializing in the treatment of obstructive sleep apnea (OSA), has been ... focus for Nyxoah is obtaining FDA approval for the Genio system ...

Advertisement The FDA first announced two months ago that ... and Drug Administration for treating moderate to severe obstructive sleep apnea. Health News // 4 hours ago Missouri judge partially ...

Spring-based Texas Sinus & Snoring (346-413-9313) announces an innovative new treatment for obstructive sleep apnea, eliminating the need for the ... With the recent announcement, the center offers ...

Obstructive sleep apnea sufferers in Spring, The Woodlands, and Houston now have access to an FDA-approved new treatment from Texas Sinus and Snoring. Known as Inspire, the implantable device uses ...